• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与烟酰胺腺嘌呤二核苷酸结合的白喉毒素的晶体结构。

Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.

作者信息

Bell C E, Eisenberg D

机构信息

UCLA-DOE Laboratory of Structural Biology and Molecular Medicine, Molecular Biology Institute, USA.

出版信息

Biochemistry. 1996 Jan 30;35(4):1137-49. doi: 10.1021/bi9520848.

DOI:10.1021/bi9520848
PMID:8573568
Abstract

Diphtheria toxin (DT), a 58 kDa protein secreted by lysogenic strains of Corynebacterium diphtheriae, causes the disease diphtheria in humans by gaining entry into the cytoplasm of cells and inhibiting protein synthesis. Specifically, the catalytic (C) domain of DT transfers the ADP-ribose group of NAD to elongation factor-2 (EF-2), rendering EF-2 inactive. In order to investigate how the C-domain of DT binds NAD and catalyzes the ADP-ribosylation of EF-2, the crystal structure of DT in complex with NAD has been determined to 2.3 A resolution. This is the first crystal structure of an ADP-ribosyltransferase (ADP-RT) enzyme in complex with NAD and suggests the features of the ADP-RT fold which are important for NAD binding. The conformation of NAD in the complex and the proximity of the Glu148 carboxylate group of the C-domain to the scissile, N-glycosidic bond of NAD suggest plausible modes of catalysis of the ADP-ribosylation reaction. Residues 39-46 of the active-site loop of the C-domain become disordered upon NAD binding, suggesting a potential role for this loop in the recognition of the ADP-ribose acceptor substrate, EF-2. The negatively charged phosphates and two ribose hydroxyls of NAD are not in direct contact with any atoms of the C-domain. Instead, they form an exposed surface which appears to be presented for recognition by EF-2. Structural alignments of the DT-NAD complex with the structures of other members of the ADP-RT family suggest how NAD may bind to these other enzymes.

摘要

白喉毒素(DT)是一种由产毒株白喉棒状杆菌分泌的58 kDa蛋白质,它通过进入细胞胞质并抑制蛋白质合成,从而导致人类患白喉病。具体而言,DT的催化(C)结构域将NAD的ADP - 核糖基团转移至延伸因子2(EF - 2),使EF - 2失活。为了研究DT的C结构域如何结合NAD并催化EF - 2的ADP - 核糖基化,已确定了DT与NAD复合物的晶体结构,分辨率为2.3 Å。这是ADP - 核糖基转移酶(ADP - RT)与NAD复合物的首个晶体结构,并揭示了对NAD结合很重要的ADP - RT折叠的特征。复合物中NAD的构象以及C结构域的Glu148羧基与NAD的可裂解N - 糖苷键的接近程度表明了ADP - 核糖基化反应可能的催化模式。C结构域活性位点环的39 - 46位残基在结合NAD后变得无序,表明该环在识别ADP - 核糖受体底物EF - 2中可能发挥作用。NAD带负电荷的磷酸基团和两个核糖羟基不与C结构域的任何原子直接接触。相反,它们形成一个暴露表面,似乎是为了被EF - 2识别而呈现。DT - NAD复合物与ADP - RT家族其他成员结构的比对表明了NAD可能如何与这些其他酶结合。

相似文献

1
Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.与烟酰胺腺嘌呤二核苷酸结合的白喉毒素的晶体结构。
Biochemistry. 1996 Jan 30;35(4):1137-49. doi: 10.1021/bi9520848.
2
Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.与烟酰胺腺嘌呤二核苷酸结合的白喉毒素的晶体结构。
Adv Exp Med Biol. 1997;419:35-43. doi: 10.1007/978-1-4419-8632-0_4.
3
Crystal structure of nucleotide-free diphtheria toxin.无核苷酸白喉毒素的晶体结构
Biochemistry. 1997 Jan 21;36(3):481-8. doi: 10.1021/bi962214s.
4
Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.基于晶体结构和同源建模得到的抑制剂及NAD⁺与聚(ADP-核糖)聚合酶的结合情况
Biochemistry. 1998 Mar 17;37(11):3893-900. doi: 10.1021/bi972383s.
5
Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.肉毒梭菌rho ADP核糖基化C3外切酶的晶体结构和新型识别基序:识别特异性和催化作用的结构见解
J Mol Biol. 2001 Jan 5;305(1):95-107. doi: 10.1006/jmbi.2000.4292.
6
Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.白喉毒素催化结构域的活性位点突变:组氨酸-21在烟酰胺腺嘌呤二核苷酸结合及延伸因子2的ADP核糖基化中的作用
Biochemistry. 1994 May 3;33(17):5155-61. doi: 10.1021/bi00183a019.
7
Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.来自一种ADP核糖基化毒素与烟酰胺腺嘌呤二核苷酸复合物结构的进化与机制
Nat Struct Biol. 1999 Oct;6(10):932-6. doi: 10.1038/13300.
8
Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.由白喉毒素催化的真核生物延伸因子2的ADP核糖基化的过渡态结构。
Biochemistry. 2004 Feb 10;43(5):1204-12. doi: 10.1021/bi035907z.
9
Unusual conformation of nicotinamide adenine dinucleotide (NAD) bound to diphtheria toxin: a comparison with NAD bound to the oxidoreductase enzymes.与白喉毒素结合的烟酰胺腺嘌呤二核苷酸(NAD)的异常构象:与结合到氧化还原酶的NAD的比较。
Protein Sci. 1997 Oct;6(10):2084-96. doi: 10.1002/pro.5560061004.
10
The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.源于晶体结构和诱变作用的聚(ADP - 核糖)聚合酶延伸和分支反应机制。
J Mol Biol. 1998 Apr 24;278(1):57-65. doi: 10.1006/jmbi.1998.1673.

引用本文的文献

1
Paradigms of convergent evolution in enzymes.酶的趋同进化模式。
FEBS J. 2025 Feb;292(3):537-555. doi: 10.1111/febs.17332. Epub 2024 Nov 22.
2
Toxin-mediated depletion of NAD and NADP drives persister formation in a human pathogen.毒素介导的 NAD 和 NADP 消耗导致人类病原体中持续存在形成。
EMBO J. 2024 Nov;43(21):5211-5236. doi: 10.1038/s44318-024-00248-5. Epub 2024 Sep 25.
3
General ADP-Ribosylation Mechanism Based on the Structure of ADP-Ribosyltransferase-Substrate Complexes.基于 ADP-核糖基转移酶-底物复合物结构的通用 ADP-核糖基化机制。
Toxins (Basel). 2024 Jul 11;16(7):313. doi: 10.3390/toxins16070313.
4
Mono-ADP-Ribosylation of Peptides: An Overview of Synthetic and Chemoenzymatic Methodologies.肽的单磷酸腺苷核糖基化:合成及化学酶法概述
Chembiochem. 2024 Dec 16;25(24):e202400440. doi: 10.1002/cbic.202400440. Epub 2024 Sep 5.
5
ADP-ribosylation from molecular mechanisms to therapeutic implications.ADP-核糖基化:从分子机制到治疗意义。
Cell. 2023 Oct 12;186(21):4475-4495. doi: 10.1016/j.cell.2023.08.030.
6
ADP-Ribosylation in Antiviral Innate Immune Response.抗病毒天然免疫反应中的ADP核糖基化作用
Pathogens. 2023 Feb 12;12(2):303. doi: 10.3390/pathogens12020303.
7
Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.细胞毒性酶作为抗癌药物的递呈进展。
Molecules. 2022 Jun 14;27(12):3836. doi: 10.3390/molecules27123836.
8
Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.针对细菌感染的疫苗接种:挑战、进展及聚焦于细胞内细菌的新方法
Vaccines (Basel). 2022 May 10;10(5):751. doi: 10.3390/vaccines10050751.
9
PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites.聚腺苷二磷酸核糖聚合酶(PARP)抑制剂捕获 PARP2 并改变 PARP2 在 DNA 损伤部位的募集方式。
Nucleic Acids Res. 2022 Apr 22;50(7):3958-3973. doi: 10.1093/nar/gkac188.
10
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword.聚(ADP-核糖)聚合酶抑制剂与髓系肿瘤:一把双刃剑
Cancers (Basel). 2021 Dec 20;13(24):6385. doi: 10.3390/cancers13246385.